- Home
- MLYS vs RSKD Comparison
MLYS vs RSKD Comparison
Compare MLYS & RSKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- RSKD
- Stock Information
- Founded
- MLYS 2019
- RSKD 2012
- Country
- MLYS United States
- RSKD United States
- Employees
- MLYS N/A
- RSKD N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- RSKD EDP Services
- Sector
- MLYS Health Care
- RSKD Technology
- Exchange
- MLYS Nasdaq
- RSKD Nasdaq
- Market Cap
- MLYS 890.6M
- RSKD 851.6M
- IPO Year
- MLYS 2023
- RSKD 2021
- Fundamental
- Price
- MLYS $14.89
- RSKD $4.56
- Analyst Decision
- MLYS Strong Buy
- RSKD Hold
- Analyst Count
- MLYS 4
- RSKD 7
- Target Price
- MLYS $27.00
- RSKD $5.79
- AVG Volume (30 Days)
- MLYS 869.6K
- RSKD 860.4K
- Earning Date
- MLYS 08-12-2025
- RSKD 08-18-2025
- Dividend Yield
- MLYS N/A
- RSKD N/A
- EPS Growth
- MLYS N/A
- RSKD N/A
- EPS
- MLYS N/A
- RSKD N/A
- Revenue
- MLYS N/A
- RSKD $335,825,000.00
- Revenue This Year
- MLYS N/A
- RSKD $6.20
- Revenue Next Year
- MLYS N/A
- RSKD $9.38
- P/E Ratio
- MLYS N/A
- RSKD N/A
- Revenue Growth
- MLYS N/A
- RSKD 7.96
- 52 Week Low
- MLYS $8.24
- RSKD $3.94
- 52 Week High
- MLYS $18.38
- RSKD $6.00
- Technical
- Relative Strength Index (RSI)
- MLYS 55.68
- RSKD 40.66
- Support Level
- MLYS $14.26
- RSKD $4.01
- Resistance Level
- MLYS $15.55
- RSKD $5.29
- Average True Range (ATR)
- MLYS 0.85
- RSKD 0.21
- MACD
- MLYS 0.18
- RSKD -0.08
- Stochastic Oscillator
- MLYS 77.53
- RSKD 42.75
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About RSKD Riskified Ltd.
Riskified Ltd has built a next-generation eCommerce risk management platform that allows online merchants to create trusted relationships with their consumers. It generates revenue by granting merchants access to its eCommerce risk management platform and reviewing and approving eCommerce transactions for legitimacy. Its merchants include some of the ecommerce brands including Wayfair, Lastminute.com, SHEIN, and Macy's. Its merchants operate in a variety of verticals, including Payments, Money Transfer & Crypto, Tickets & Travel, Electronics, Home, Fashion & Luxury Goods, General Retail and Food. The company derived maximum revenue from Israel.